Showing 1 to 20 of 276 bills
| Bill Title | Introduced | Latest Action |
|---|---|---|
|
A 3591
(New Jersey - 2026-2027 Regular Session)
Requires NJ FamilyCare reimbursement for pediatric medication management services provided for certain children by licensed pharmacist. |
Jan 13 2026 |
Reported And Referred To Assembly Aging And Human Services Committee
Oct 05 2026 |
|
HB 5284
(Illinois - 104th Regular Session)
Human Rights-Menopause Care |
Feb 05 2026 |
Public Act . . . . . . . . . 104-0793
Aug 07 2026 |
|
H 5303
(Massachusetts - 194th Legislature (2025-2026))
An Act expanding access to perimenopause and menopause care |
Mar 26 2026 |
Committee Recommended Ought To Pass And Referred To The Committee On House Ways And Means
Jul 23 2026 |
|
HB 5492
(Illinois - 104th Regular Session)
Prescription Hormone Therapy |
Feb 06 2026 |
Public Act . . . . . . . . . 104-0537
Jun 29 2026 |
|
HR 7
(Georgia - 2026 Special Session)
Endometrial cancer as public health concern; recognize |
Jun 17 2026 |
House Read And Adopted
Jun 17 2026 |
|
HB 7357
(Rhode Island - 2026 Regular Session)
An Act Relating To Health And Safety -- Sensitive Healthcare Information Privacy Act |
Jan 28 2026 |
06/11/2026 House Passed Sub A
Jun 11 2026 |
|
S 9088
(New York - 2025 Regular Session)
Requires the registration of data brokers and establishing a data deletion mechanism for consumers |
Jan 30 2026 |
Referred To Consumer Affairs And Protection
Jun 04 2026 |
|
K 1580
(New York - 2025 Regular Session)
Memorializing Governor Kathy Hochul to proclaim October 2026, as Breast Cancer Awareness Month in the State of New York |
Jun 02 2026 |
Adopted
Jun 03 2026 |
|
HB 8587
(Rhode Island - 2026 Regular Session)
An Act Relating To Insurance -- Accident And Sickness Insurance Policies |
May 27 2026 |
06/02/2026 Committee Recommended Measure Be Held For Further Study
Jun 02 2026 |
|
S 7495
(New York - 2025 Regular Session)
Enacts the menopause awareness improvement act |
Apr 17 2025 |
Referred To Health
Jun 02 2026 |
|
HB 2584
(Illinois - 104th Regular Session)
Ins-Prior Auth Hiv Drug Access |
Feb 04 2025 |
Senate Committee Amendment No. 2 Rule 3-9(A) / Re-Referred To Assignments
Jun 01 2026 |
|
A 10045
(New York - 2025 Regular Session)
Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause |
Jan 30 2026 |
Returned To Assembly
Jun 01 2026 |
|
A 9642
(New York - 2025 Regular Session)
Requires the registration of data brokers and establishing a data deletion mechanism for consumers |
Jan 21 2026 |
Print Number 9642a
Jun 01 2026 |
|
S 8894
(New York - 2025 Regular Session)
Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause |
Jan 13 2026 |
Substituted By A10045
Jun 01 2026 |
|
SB 2805
(Illinois - 104th Regular Session)
Long-Term Care Bill Of Rights |
Jan 13 2026 |
Added As Co-Sponsor Sen. Rachel Ventura
May 29 2026 |
|
SB 2890
(Rhode Island - 2026 Regular Session)
An Act Relating To Insurance -- Accident And Sickness Insurance Policies |
Mar 04 2026 |
05/29/2026 Referred To House Health & Human Services
May 29 2026 |
|
SJR 62
(New Jersey - 2026-2027 Regular Session)
Designates October of each year as "Menopause Awareness Month," October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey. |
Jan 13 2026 |
Received In The Assembly, Referred To Assembly Community Development And Women's Affairs Committee
May 28 2026 |
|
A 6927
(New York - 2025 Regular Session)
Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy |
Mar 18 2025 |
Print Number 6927a
May 28 2026 |
|
HR 290
(Louisiana - 2026 Regular Session)
HEALTH: Requests the Louisiana Department of Health to study the effects of gender affirming therapy on mental health |
May 18 2026 |
Read By Title, Under The Rules, Referred To The Committee On Health And Welfare.
May 19 2026 |
|
S 10466
(New York - 2025 Regular Session)
Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy |
May 15 2026 |
Referred To Higher Education
May 15 2026 |
Showing 1 to 20 of 276 bills
